Next-generation regulatory T cell therapy
Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …
Treg enhancing therapies to treat autoimmune diseases
PJ Eggenhuizen, BH Ng, JD Ooi - International journal of molecular …, 2020 - mdpi.com
Regulatory T cells (Tregs) are a small yet critical subset of CD4+ T cells, which have the role
of maintaining immune homeostasis by, for example, regulating self-tolerance, tumor …
of maintaining immune homeostasis by, for example, regulating self-tolerance, tumor …
The polygenic and monogenic basis of blood traits and diseases
Blood cells play essential roles in human health, underpinning physiological processes
such as immunity, oxygen transport, and clotting, which when perturbed cause a significant …
such as immunity, oxygen transport, and clotting, which when perturbed cause a significant …
[HTML][HTML] The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes
S Dong, KJ Hiam-Galvez, CT Mowery, KC Herold… - JCI insight, 2021 - ncbi.nlm.nih.gov
BACKGROUND A previous phase I study showed that the infusion of autologous Tregs
expanded ex vivo into patients with recent-onset type 1 diabetes (T1D) had an excellent …
expanded ex vivo into patients with recent-onset type 1 diabetes (T1D) had an excellent …
Low-dose IL-2 therapy in autoimmune and rheumatic diseases
H Graßhoff, S Comdühr, LR Monne, A Müller… - Frontiers in …, 2021 - frontiersin.org
Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …
Current and future therapies for type 1 diabetes
BJ von Scholten, FF Kreiner, SCL Gough… - Diabetologia, 2021 - Springer
In type 1 diabetes, insulin remains the mature therapeutic cornerstone; yet, the increasing
number of individuals developing type 1 diabetes (predominantly children and adolescents) …
number of individuals developing type 1 diabetes (predominantly children and adolescents) …
Modulation of regulatory T cell function and stability by co-inhibitory receptors
LE Lucca, M Dominguez-Villar - Nature Reviews Immunology, 2020 - nature.com
Regulatory T (Treg) cells constitute a dynamic population that is essential for controlling
immune responses in health and disease. Defects in Treg cell function and decreases in …
immune responses in health and disease. Defects in Treg cell function and decreases in …
IL-2-based approaches to Treg enhancement
F Harris, YA Berdugo, T Tree - Clinical and Experimental …, 2023 - academic.oup.com
Immune homeostasis is heavily dependent on the action of regulatory T cells (Tregs) which
act to suppress the activation of many immune cell types including autoreactive conventional …
act to suppress the activation of many immune cell types including autoreactive conventional …
A genetics-led approach defines the drug target landscape of 30 immune-related traits
H Fang, H De Wolf, B Knezevic, KL Burnham… - Nature …, 2019 - nature.com
Most candidate drugs currently fail later-stage clinical trials, largely due to poor prediction of
efficacy on early target selection. Drug targets with genetic support are more likely to be …
efficacy on early target selection. Drug targets with genetic support are more likely to be …
[HTML][HTML] Effects of interleukin-2 in immunostimulation and immunosuppression
JG Pol, P Caudana, J Paillet, E Piaggio… - Journal of Experimental …, 2020 - rupress.org
Background Clues supporting the existence of IL-2 emerged in 1976. That year, after
successfully expanding T cells in vitro, Morgan et al.(1976) reported the presence of a T cell …
successfully expanding T cells in vitro, Morgan et al.(1976) reported the presence of a T cell …